The largest community of pharma leaders

Sandra Shpilberg

Burden of Illness in Rare Diseases

Though “rare” is the key word, ~30 million Americans are living with at least one of 7,000 rare diseases. A disease is defined as rare...

A New Era: Finding Patients for Clinical Trials

The biopharmaceutical industry has long valued the efficacy of a new molecule, the experience of a management team and the execution ability of clinical...

Recent Featured Articles

Critical challenges that Physicians are facing during the Pandemic

In September 2019, Fine Research a consultancy firm specialized in Healthcare Online and Qual data collection in LatAm, began an unprecedented study in the...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in Pharma when it comes to...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare Scenario

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are accelerating approaches already existing within...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is “fake news.” We hear it...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board...